4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000016
PRESIDENT AND COO sold 22,500 shares at an average $496.30 ($11,166,722)
- PRESIDENT AND COO acquired 22,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENKOWITZ MICHAEL · PRESIDENT AND COO
Table I: Non-derivative
22 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,625 | $117.76 | $1,722,240 | 14,625 | I |
| 2025-12-15 | Sale : show line 2 in the form 10b5-1 | −260 | $491.18 | $127,707 | 14,365 | I |
| 2025-12-15 | Sale : show line 3 in the form 10b5-1 | −1,466 | $492.31 | $721,733 | 12,899 | I |
| 2025-12-15 | Sale : show line 4 in the form 10b5-1 | −2,596 | $493.25 | $1,280,472 | 10,303 | I |
| 2025-12-15 | Sale : show line 5 in the form 10b5-1 | −1,446 | $494.13 | $714,518 | 8,857 | I |
| 2025-12-15 | Sale : show line 6 in the form 10b5-1 | −1,442 | $495.29 | $714,207 | 6,076 | I |
| 2025-12-15 | Sale : show line 7 in the form 10b5-1 | −1,339 | $496.16 | $664,359 | 7,518 | I |
| 2025-12-15 | Sale : show line 8 in the form 10b5-1 | −520 | $497.42 | $258,658 | 5,556 | I |
| Open-market sales · 22,500 sh · avg $496.30 · $11,166,722 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-15 | Exercise or conversion : show line 23 in the form 10b5-1 Stock Options | −14,625 | 141,000 | I |
| 2025-12-15 | Exercise or conversion : show line 24 in the form 10b5-1 Stock Options | −7,875 | 6,190 | I |
Loading xslF345X05/primarydocument.xml…